Applied Genetic Technologies
(NASDAQ) AGTC
This security has been delisted. This page is retained for historical reference.
AGTC News
![2015_product_chart[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F171758%2F2015_product_chart1.jpg&w=3840&op=resize)
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAGTC Financials
Key Financial Metrics (TTM)
Gross Margin
100.00%
Operating Margin
-20390.46%
Net Income Margin
-21976.62%
Return on Equity
-123.91%
Return on Capital
-127.57%
Return on Assets
-107.11%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$325.00K
Operating Income
-$51.64M
EBITDA
-$49.13M
Operating Cash Flow
-$49.64M
Capital Expenditure
-$2.07M
Free Cash Flow
-$51.71M
Cash & ST Invst.
$34.24M
Total Debt
$20.15M
Applied Genetic Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
102
N/A
Net Income
$17.07M
+199.7%
EBITDA
-$96.00K
+99.4%
Quarterly Fundamentals
Total Cash
$34.24M
-62.2%
Total Debt
$20.15M
-17.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$10.62M
-43.8%
Short Term Debt
$9.53M
+71.3%
Return on Assets
-1.07%
N/A
Return on Invested Capital
-1.60%
N/A
Free Cash Flow
-$17.57M
-6.2%
Operating Cash Flow
-$17.39M
-9.1%